evidnet
Provides evidence-based medicine to patients.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor | €0.0 | round | |
| investor investor investor | €0.0 | round | |
* | KRW10.0b | Series B | |
| Total Funding | 000k | ||
| USD | 2021 | 2022 | 2023 |
|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 |
| EBITDA | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 |
| EV | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 |
Source: Dealroom estimates
Related Content
A healthcare IT company that provides a real-world data (RWD) and real-world evidence (RWE) platform to support physicians, clinical researchers, healthcare service providers, and patients. The company's main product, EVIX-ONE™, is a solution that enables multicenter collaborative research by leveraging EvidNet's network of partner hospitals' data.
The company's platform allows for the generation of meaningful insights from RWD, which can be used to identify potential clinical trial sites and eligible patient numbers, as well as to conduct tailored analyses. The company's services are designed to assist in the generation of evidence from a fully integrated data network, with the ultimate goal of pioneering new paradigms in data-driven, evidence-based medicine.
The company's business model is based on providing its platform and services to a variety of clients in the life sciences and healthcare sectors. These clients include pharmaceutical companies, contract research organizations (CROs), and academic medical centers. The company makes money by charging for access to its platform and for the provision of its services.
Keywords: real-world data, real-world evidence, healthcare IT, clinical research, data-driven medicine, multicenter collaborative research, life sciences, healthcare, data network, evidence-based medicine